Report cover image

MEA (Middle East & Africa) AI-assisted Medical Imaging Market

Publisher MarketStrat, Inc.
Published Aug 30, 2025
Length 24 Pages
SKU # MS20378825

Description

AI-assisted Medical Imaging Market

Report Headline

MEA is shifting from pilots to selective scale—rising from ~US$25M (2023) to ~US$500M by 2032 (~24%CAGR). GCC anchors >60% of spend with enterprise AI suites, while Sub-Saharan Africa scales low-bandwidth DR/ultrasound AI via opex models and teleradiology. This Pulse translates evidence into where to play and how to win—per country, modality, and buyer.

Five Key Stats

1. Size & pace: ~US$25M → ~US$500M (2023–2032, ~24% CAGR).
2. GCC share: >60% of regional spend (KSA, UAE, Qatar, Kuwait, Oman, Bahrain).
3. Modality mix shift: CT 36%→23%, MRI 32%→39%, X-ray/DR 16%→22% by 2032.
4. Clinical engines: Oncology, Cardiology, and Stroke account for most absolute growth.
5. Revenue streams: Hardware share declines; Software/Service rise; Cloud/Pay-per-Use grows fastest in Africa.

Buyer Benefits

Country-specific playbooks (GCC, North Africa, Sub-Saharan) with actions, partners, and pricing archetypes.
Attach-rate ladders & ASP bands to package CT/MR bundles vs. DR/US opex offers.
Procurement & hosting checklists (Arabic UI, data-residency, security/QMS for GCC; edge/offline in Africa).
Evidence-to-budget alignment (door-to-needle, TAT, dose/time saved) to unlock enterprise approvals.
Framework-driven GTM (Growth & Maturity, Ecosystem Collaboration, Solution Adoption & Growth).

Methodology & QA

Dual-lens model: top-down tie-out to global totals + bottom-up attach-rate engine (shipments, retrofit,ASPs). MEA-specific weighting (SFDA/MOHAP/SAHPRA signals; donor/PPP patterns). QA loop: sum-to-total ≤0.5%, regulatory-diff checks, evidence freshness, ASP sanity.

Report Metadata

Title: MEA (Middle East & Africa) AI-assisted Medical Imaging Market — Markintel™ Pulse (2025)
Publisher: Marketstrat Inc.
Timeframe: Base 2023; forecast to 2032
Coverage: GCC, North Africa, Sub-Saharan Africa; splits by modality, clinical area, application, revenue stream, end-use, country
Key numbers: ~US$25M → ~US$500M; ~24% CAGR
Use cases: OEM bundling, pure-play channel strategy, telerad scale-up, donor-funded programs
SKU/price block
Individual License (PDF): $1950
Team License: $2450
Enterprise License (global): $2950

Table of Contents

24 Pages
SECTION 1 - EXECUTIVE SUMMARY
The 25-second read
Size & Pace (where dollars concentrate)
Modality Mix (MEA, 2023 → 2032)
Clinical pathways (MEA, 2023 → 2032)
Revenue Stream Dynamics
Country/Cluster Snapshots
12-month actions (MEA “Pulse Quick-wins”)
SECTION 2 — RESEARCH METHODOLOGY
Scope & Segmentation
Dual-Lens Architecture
MEA-Specific Inputs & Weighting
Assumptions & calibration choices (MEA)
Quality assurance (standard Pulse QA)
Limitations & Mitigations
SECTION 3 – MARKET OVERVEW & ANALYSIS - MEA
MEA Market Snapshot
Logical Clusters & Why They Matter
Key Growth Catalysts
Structural Barriers & Mitigation
Actionable Recommendations by Vendor Type
Sequencing Roadmap
Executive Takeaways
SECTION 4 – MARKET ESTIMATES & FORECASTS - MEA
MEA Market by Clinical Area (2023-2032)
Growth Drivers & Restraints
MEA Market by Modality (2023-2032)
Modality Share Shifts
MEA Market by Revenue Stream (2023-2032)
Revenue Stream Shifts & Strategic Implications
MEA Market by Clinical Application (2023-2032)
Clinical Application Shifts & Takeaways
MEA Market by End-Use Organization (2023-2032)
End-User Adoption Patterns
MEA Market by AI Technology (2023-2032)
Technology Shifts and Takeaways
SECTION 5 – MARKINTEL SOLUTION ADOPTION & GROWTH MATRIX – MEA
Interpretation & Operating Roadmap
Execution Checklist
SECTION 6 – MARKINTEL ECOSTSYSTEM COLLABORATION MATRIX - MEA
Partnership Playbook
Operating Roadmap & Key Execution Metrics
SECTION 7 – GTM AT-A-GLANCE (MEA)
GTM Readiness Radar – MEA
Country Cluster Heatmap – MEA
GTM Timeline – Pilot to Scale (2024-2029) - MEA
Adjacency-Opportunity Radar - MEA
GTM Maturity Highlights - MEA
Regulatory Velocity - MEA
Attach Rate Trends - MEA
List of Figures
Figure 1: Markintel Solution Adoption & Growth Matrix – MEA
Figure 2: Markintel Ecosystem Collaboration Matrix – MEA
Figure 3: GTM Readiness Radar – MEA
Figure 4: Country Cluster Heatmap – MEA
Figure 5: GTM Timeline – Pilot to Scale (2024-2029) – MEA
Figure 6: Adjacency-Opportunity Radar – MEA
Figure 7: Regulatory Velocity - MEA
Figure 8: Attach Rate Trends - MEA
List of Tables
Table 1: Middle East and African (MEA) Market by Clinical Area (2023-2032, USD Million)
Table 2: Middle East and African (MEA) Market by Modality (2023-2032, USD Million)
Table 3: Middle East and African (MEA) Market by Revenue Stream (2023-2032, USD Million)
Table 4: Middle East and African (MEA) Market by Clinical Application (2023-2032, USD Million)
Table 5: Middle East and African (MEA) Market by End-Use Organization (2023-2032, USD Million)
Table 6: Middle East (MEA) Market AI Technology (2023-2032, USD Million)

Search Inside Report

How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.